Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema von Zuraw, Bruce L, Busse, Paula J, White, Martha, Jacobs, Joshua, Lumry, William, Baker, James, Craig, Timothy, Grant, J. Andrew, Hurewitz, David, Bielory, Leonard, Cartwright, William. E, Koleilat, Majed, Ryan, Walter, Schaefer, Oren, Manning, Michael, Patel, Pragnesh, Bernstein, Jonathan A, Friedman, Roger A, Wilkinson, Robert, Tanner, David, Kohler, Gary, Gunther, Glenne, Levy, Robyn, McClellan, James, Redhead, Joseph, Guss, David, Heyman, Eugene, Blumenstein, Brent A, Kalfus, Ira, Frank, Michael M

Volltext

Rice-induced anaphylactoid reaction von Borchers, S.D. (The Ohio State University College of Medicine, Columbus, OH), Li, B.U.K, Friedman, R.A, McClung, H.J

Volltext

Sulfasalazine‐Induced Hepatotoxicity in Children with Inflammatory Bowel Disease von Boyer, Debra L., Li, B Ulysses K., Fyda, John N., Friedman, Roger A.

Volltext

Rice-Induced Anaphylactoid Reaction von Borchers, Susan D., Li, B U.K., Friedman, Roger A., McClung, H. Juhling

Volltext

Sulfasalazine-Induced Hepatotoxicity in Children with Inflammatory Bowel Disease von Boyer, Debra L., Li, B Ulysses K., Fyda, John N., Friedman, Roger A.

Volltext

Antigen-induced eustachian tube obstruction: An intranasal provocative challenge test von Ackerman, Michael N., Friedman, Roger A., Doyle, William J., Bluestone, Charles D., Fireman, Philip

Volltext

Immunologic-mediated eustachian tube obstruction: a double-blind crossover study von Friedman, Roger A., Doyle, William J., Casselbrant, Margaretha L., Bluestone, Charles, Fireman, Philip

Volltext

Eosinophilic nonallergic rhinitis in children von Rupp, G H, Friedman, R A

Volltext

Pneumocystis carinii Pneumonia in an Infant with the Hyperimmunoglobulinemia E Syndrome von PACINI, D. L, FRIEDMAN, R. A, BRADY, M. T, SHANNON, B. T, QUALMAN, S. J, ANDERSON, D. C

Volltext

Early Origins of Divergent Patterns of Morphological Evolution on the Mammal and Reptile Stem-Lineages von Brocklehurst, Neil, Ford, David P, Benson, Roger B J

Volltext

Recurrent Glioblastoma Treated with Recombinant Poliovirus von Desjardins, Annick, Gromeier, Matthias, Herndon, James E, Beaubier, Nike, Bolognesi, Dani P, Friedman, Allan H, Friedman, Henry S, McSherry, Frances, Muscat, Andrea M, Nair, Smita, Peters, Katherine B, Randazzo, Dina, Sampson, John H, Vlahovic, Gordana, Harrison, William T, McLendon, Roger E, Ashley, David, Bigner, Darell D

Volltext

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma von SAMPSON, John H, HEIMBERGER, Amy B, REARDON, David A, SAWAYA, Raymond, SCHMITTLING, Robert J, WEIMING SHI, VREDENBURGH, James J, BIGNER, Darell D, ARCHER, Gary E, ALDAPE, Kenneth D, FRIEDMAN, Allan H, FRIEDMAN, Henry S, GILBERT, Mark R, HERNDON, James E, MCLENDON, Roger E, MITCHELL, Duane A

Volltext

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma von Diplas, Bill H., He, Xujun, Brosnan-Cashman, Jacqueline A., Liu, Heng, Chen, Lee H., Wang, Zhaohui, Moure, Casey J., Killela, Patrick J., Loriaux, Daniel B., Lipp, Eric S., Greer, Paula K., Yang, Rui, Rizzo, Anthony J., Rodriguez, Fausto J., Friedman, Allan H., Friedman, Henry S., Wang, Sizhen, He, Yiping, McLendon, Roger E., Bigner, Darell D., Jiao, Yuchen, Waitkus, Matthew S., Meeker, Alan K., Yan, Hai

Volltext

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy von Gromeier, Matthias, Brown, Michael C., Zhang, Gao, Lin, Xiang, Chen, Yeqing, Wei, Zhi, Beaubier, Nike, Yan, Hai, He, Yiping, Desjardins, Annick, Herndon, James E., Varn, Frederick S., Verhaak, Roel G., Zhao, Junfei, Bolognesi, Dani P., Friedman, Allan H., Friedman, Henry S., McSherry, Frances, Muscat, Andrea M., Lipp, Eric S., Nair, Smita K., Khasraw, Mustafa, Peters, Katherine B., Randazzo, Dina, Sampson, John H., McLendon, Roger E., Bigner, Darell D., Ashley, David M.

Volltext

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma von Sampson, John H, Schmittling, Robert J, Archer, Gary E, Congdon, Kendra L, Nair, Smita K, Reap, Elizabeth A, Desjardins, Annick, Friedman, Allan H, Friedman, Henry S, Herndon, 2nd, James E, Coan, April, McLendon, Roger E, Reardon, David A, Vredenburgh, James J, Bigner, Darell D, Mitchell, Duane A

Volltext

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination von Batich, Kristen A, Reap, Elizabeth A, Archer, Gary E, Sanchez-Perez, Luis, Nair, Smita K, Schmittling, Robert J, Norberg, Pam, Xie, Weihua, Herndon, 2nd, James E, Healy, Patrick, McLendon, Roger E, Friedman, Allan H, Friedman, Henry S, Bigner, Darell, Vlahovic, Gordana, Mitchell, Duane A, Sampson, John H

Volltext

Extinction of fish-shaped marine reptiles associated with reduced evolutionary rates and global environmental volatility von Fischer, Valentin, Bardet, Nathalie, Benson, Roger B. J., Arkhangelsky, Maxim S., Friedman, Matt

Volltext

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas von Killela, Patrick J, Pirozzi, Christopher J, Healy, Patrick, Reitman, Zachary J, Lipp, Eric, Rasheed, B Ahmed, Yang, Rui, Diplas, Bill H, Wang, Zhaohui, Greer, Paula K, Zhu, Huishan, Wang, Catherine Y, Carpenter, Austin B, Friedman, Henry, Friedman, Allan H, Keir, Stephen T, He, Jie, He, Yiping, McLendon, Roger E, Herndon, 2nd, James E, Yan, Hai, Bigner, Darell D

Volltext

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma von Sampson, John H., Aldape, Kenneth D., Archer, Gary E., Coan, April, Desjardins, Annick, Friedman, Allan H., Friedman, Henry S., Gilbert, Mark R., Herndon, James E., McLendon, Roger E., Mitchell, Duane A., Reardon, David A., Sawaya, Raymond, Schmittling, Robert, Shi, Weiming, Vredenburgh, James J., Bigner, Darell D., Heimberger, Amy B.

Volltext

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma von Reardon, David A., Desjardins, Annick, Peters, Katherine B., Gururangan, Sridharan, Sampson, John H., McLendon, Roger E., Herndon, James E., Bulusu, Anuradha, Threatt, Stevie, Friedman, Allan H., Vredenburgh, James J., Friedman, Henry S.

Volltext